Privately-held French biotech focused on providing immuno-therapeutics Biomunex Pharmaceuticals today announced a capital ...

Shares in Enanta Pharmaceuticals, a US biotech creating small molecule drugs for viral infections and immunological diseases, ...

US obesity firm Metsera has presented new data that demonstrates why pharma giant Pfizer is paying up to $7.3 billion to buy ...

Shares of US clinical-stage biotech Dogwood Therapeutics soared a massive 43% to $7.91 yesterday, on the news it has secured ...

US eye disease specialist Kala Bio saw its shares close down almost 90% at $2.04 yesterday, after it revealed disappointing ...

President Donald Trump has called on US industries to put America first, and the biopharmaceutical sector is answering that ...

US health technology body ICER will review the comparative clinical effectiveness and value of four COVID-19 vaccines: Pfizer ...

Japanese drugmaker Eisai and US biotech major Biogen have presented new clinical data from a post-hoc sub-group analysis of ...

For years, rare diseases were seen as a safe harbor for biotech and pharma: small patient populations, little competition, ...

Since my first job in healthcare over 25 years ago to my current role within Gilead UK&I, I have seen time and time again ...

Boston, USA-based biotech Cue Biopharma has announced the appointment of Dr Usman Azam as its new president and chief executive (CEO), supporting the company’s advancement of its first-in-class ...

Danish pharma major Novo Nordisk has announced to updates in a single day on filings to the US Food and Drug Administration ...